SB936

Pennsylvania SB936 requires health insurance policies to cover postexposure prophylaxis HIV medication.

Pennsylvania SB936 mandates that health insurance policies cover the expenses of postexposure prophylaxis HIV medication, which is approved by the United States Food and Drug Administration. The bill prohibits insurance providers from moving these medications into a specialty tier solely for monetary gains and requires that no health care plan may impose counseling from an infectious disease specialist or immunologist to receive the medication unless medically necessary. The act will take effect in 60 days.